Peripheral markers in testing pathophysiological hypotheses and diagnosing Alzheimer's disease

Area of Science:

• Neuroscience
• Molecular Biology
• Biochemistry

Background:

• Alzheimer's disease (AD) involves alterations in amyloid precursor protein (APP) metabolism, calcium regulation, oxidative metabolism, and signal transduction.
• Studying AD's molecular mechanisms is limited by the unavailability of postmortem brain tissue.
• There is a need for accessible human tissue models that reflect AD's pathophysiology.

Purpose of the Study:

• To establish cultured peripheral skin fibroblasts from AD patients as a representative human tissue model.
• To investigate dynamic cellular processes in AD, including signal transduction, ionic homeostasis, oxidative metabolism, and APP processing.
• To explore the potential of peripheral cells and fluids as diagnostic biomarkers for AD.

Main Methods:

• Utilizing cultured skin fibroblasts derived from Alzheimer's disease patients.
• Examining molecular mechanisms such as APP processing, calcium regulation, oxidative metabolism, and signal transduction pathways.
• Analyzing peripheral body fluids like plasma and cerebrospinal fluid (CSF) for potential biomarkers.

Main Results:

• Cultured peripheral fibroblasts serve as a viable model for studying AD-related molecular alterations.
• Peripheral cells and body fluids show potential for identifying diagnostic markers for AD.
• This approach complements studies using postmortem brain tissue.

Conclusions:

• Peripheral tissue models, specifically cultured skin fibroblasts from AD patients, are crucial for advancing Alzheimer's disease research.
• Peripheral biomarkers derived from cells and body fluids hold significant promise for improving AD diagnosis.
• Further research into these peripheral markers could lead to earlier and more accurate detection of Alzheimer's disease.